#United States #Frisco #WindRose Health #Court Square #Soleo Health

Strategic Investment to Propel Soleo Health's Growth

Court Square Capital Partners and WindRose Health Investors have successfully closed a joint investment agreement with Soleo Health, a provider of specialty pharmacy and infusion services located in Frisco, Texas. This partnership aims to enhance the delivery of Complex Specialty Pharmacy and infusion services to a growing patient base and meet increasing demand.

Overview of Soleo Health

Soleo Health is dedicated to providing high-quality specialty care to over 22,000 patients annually. With an expansive network of specialty home infusion pharmacies and ambulatory infusion suites, Soleo delivers critical care in the comfort of patients’ homes or in community settings. Their comprehensive approach ensures that patients receive access to sophisticated and life-saving therapies across various health conditions.

Drew Walk, Co-Founder, President, and CEO of Soleo Health, expressed enthusiasm about this partnership. He emphasized that the alignment of values and commitment between Soleo, Court Square, and WindRose is central to improving overall patient care. Their collective expertise aims to uphold Soleo's reputation as a top healthcare service provider while further advancing the industry with a skilled team.

Implications of the Investment

The investment from Court Square and WindRose is expected to bolster Soleo’s capabilities to serve more patients across all 50 states while maintaining its commitment to high-touch services. The funds will facilitate their business recapitalization and provide essential resources for further expansion.

CJ Burnes, a partner at WindRose, highlighted the market-leading and differentiated services offered by Soleo. He mentioned that their collaboration with Court Square is set to accelerate the company's growth trajectory, ensuring that Soleo can maintain its standards of exceptional patient care while catering to a broader clientele.

David Nguyen, Managing Partner at Court Square, reaffirmed that the essence of Soleo’s founder-led identity aligns perfectly with their investment strategy. They are eager to collaborate with Soleo’s executive team to support its continued growth within the healthcare sector.

Expert Advisory Team

In securing this investment, Soleo Health was supported by Houlihan Lokey as its exclusive financial advisor, while Polsinelli PC provided legal counsel for Soleo’s management team. WindRose and Court Square were also represented legally by Latham & Watkins LLP and Dechert LLP, with Cantor Fitzgerald serving as their financial advisor.

Industry Background

Soleo Health addresses a crucial aspect of healthcare by providing complex specialty pharmacy services, including infusion therapy, in patients' homes or at alternate care sites. The company’s interdisciplinary team of clinical pharmacists, nurses, and care specialists collaborates closely with healthcare partners to optimize patient care solutions. This synergy leads to significant clinical and economic benefits while enhancing patient experiences.

With 26 pharmacy locations and licensing across all 50 states, Soleo Health is accredited by multiple prominent organizations, including URAC and The Joint Commission. In addition to their pharmacy services, Soleo operates more than 30 infusion suites and centers across the U.S., expanding their ability to meet patient needs conveniently.

In an era where the demand for personalized healthcare continues to rise, this investment signifies a critical step towards advancing accessible and high-quality healthcare services, indicating a promising future for Soleo Health and its stakeholders.

For further details about Soleo Health and their offerings, visit soleohealth.com.

About Court Square and WindRose

Court Square Capital Partners operates from New York and has over 40 years of experience in the private equity space. Since its inception, the firm has facilitated over 245 platform investments focusing on industries with compelling growth potential. On the other hand, WindRose Health Investors specializes in equity investments in profitable healthcare service companies. With a robust portfolio exceeding $3.6 billion, WindRose targets innovative, cost-effective healthcare solutions around the U.S.

Court Square and WindRose’s partnership with Soleo Health represents a vital commitment to enhancing patient care services across the nation.